A Comparison Of Markov Cohort And Discrete Event Simulation Models In Cost-Effectiveness Analysis Of Sorafenib And Everolimus In 3rd Line Metastatic Renal-Cell Carcinoma In The Czech Republic

OBJECTIVES: Markov cohort (MC) and discrete-event simulation (DES) models are inherently different. Therefore, they are rarely used in economic evaluation of the same disease. Sorafenib and everolimus are cornerstones of current metastatic renal-cell carcinoma (mRCC) treatment in 2nd line, however,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Value in health 2017-10, Vol.20 (9), p.A752-A753
Hauptverfasser:	Mlcoch, T, Lamblova, K, Ornstova, E, Dolezal, T
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Cohort analysis Comparable worth Computer applications Cost analysis Death & dying Efficacy Health care Kidney cancer Kidney diseases Markov analysis Metastases Metastasis Oncology Quality adjusted life years Renal cell carcinoma Savings Sensitivity analysis Simulation Targeted cancer therapy Willingness to pay
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!